MS News & Perspectives

MS News & Perspectives

Multiple Sclerosis News Today seeks to fill an unmet need in healthcare news journalism by providing patients and their families with a reliable news journal on MS that they can engage with on a daily basis for the latest news and MS resources.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(500)

Atara Planning Phase 3 Trials of ATA188 in Non-active SPMS, PPMS & Seizing the Day With MS

Atara Planning Phase 3 Trials of ATA188 in Non-active SPMS, PPMS & Seizing the Day With MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Atara may open two Phase 3 clinical trials of ATA188, an immunotherapy targeting EBV-infected B-cells in non-activ...

27 Apr 202211min

MS Patients May Meet Criteria for Sjögren’s Diagnosis & Managing a Wheelchair Mishap

MS Patients May Meet Criteria for Sjögren’s Diagnosis & Managing a Wheelchair Mishap

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how symptoms of Sjögren’s syndrome, including dry eyes and mouth, were observed among 16 people with multiple sclerosis...

25 Apr 202210min

NVG-291 Trial in MS Patients Anticipated & How To Improve MS Patient-Provider Relationships

NVG-291 Trial in MS Patients Anticipated & How To Improve MS Patient-Provider Relationships

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how NVG-291, an experimental therapy to promote nervous system repair, has been well-tolerated in an ongoing Phase 1 s...

22 Apr 202217min

Eight More Patients Cleared for Foralumab Treatment & Crossing the Lemtrada Finish Line

Eight More Patients Cleared for Foralumab Treatment & Crossing the Lemtrada Finish Line

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how the FDA has cleared eight more SPMS patients for treatment with foralumab nasal spray, under a specia...

20 Apr 202211min

Long-term Evobrutinib Safe, Effective in Relapsing MS & Managing Life With MS

Long-term Evobrutinib Safe, Effective in Relapsing MS & Managing Life With MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib appeared to safely and effectively reduced relapse rates in adults with relapsing MS fo...

18 Apr 202210min

CONSONANCE Update Shows Ocrevus’ Effectiveness After 1 Year & Managing UTI Admissions and More

CONSONANCE Update Shows Ocrevus’ Effectiveness After 1 Year & Managing UTI Admissions and More

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how 75% of SPMS and PPMS patients in the CONSONANCE trial showed no evidence of disease progression a...

15 Apr 202210min

Questionnaire To Help Women Talk About Sexual Health and MS & Staying Busy With MS

Questionnaire To Help Women Talk About Sexual Health and MS & Staying Busy With MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a questionnaire tailored for women with multiple sclerosis may help them talk to their doctor about their sexual h...

13 Apr 202210min

No Link Between Herpes Infection and MS Risk & Artist Turns MRI Scans Into Art

No Link Between Herpes Infection and MS Risk & Artist Turns MRI Scans Into Art

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how infection with the herpes simplex virus does not increase the risk of multiple sclerosis, accordi...

11 Apr 202211min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
sinnsyn
forskningno
villmarksliv
liberal-halvtime
rss-paradigmepodden
rekommandert
fjellsportpodden
aldring-og-helse-podden
rss-rekommandert
vett-og-vitenskap-med-gaute-einevoll
dekodet-2
rss-inn-til-kjernen-med-sunniva-rose
tomprat-med-gunnar-tjomlid
kvinnehelsepodden
grunnstoffene
rss-overskuddsliv
rss-bondevennen